Neurana Pharmaceuticals competitors and similar companiesClear all

Neurana Pharmaceuticals's competitors and similar companies include Keros Therapeutics, Apotheekzorg Bladel and Zhimeng Biopharma.
Neurana Pharmaceuticals
Neurana Pharmaceuticals
Neurana Pharmaceuticals is a company developing a treatment for acute muscle spasm.
Keros Therapeutics
Keros Therapeutics
Keros Therapeutics is a biotechnology company dedicated to the discovery and development of therapeutics for hematological and musculoskeletal disorders.
Apotheekzorg Bladel
Apotheekzorg Bladel
Apotheekzorg Bladel is a provider of healthcare services.
Zhimeng Biopharma
Zhimeng Biopharma
Zhimeng Biopharma (上海挚盟医药科技有限公司) is a biotech company developing medicines for the treatment of chronic hepatitis B (CHB) and severe neurological diseases.
Founding Date
Founding Date
2013
Founding Date
2015
Founding Date
N/A
Founding Date
2017
Type
Type
Private
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
San Diego, US HQ
San Diego, US
Locations
Lexington, US HQ
Locations
Bladel, NL HQ
Locations
HQ
Employees
Employees
2
Employees
23
Employees
1143% increase
Employees
12

Funding

Latest funding round
Latest funding round
$ 60m (almost 5 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 142m (over 3 years ago)
Total funding raised
Total funding raised
$ 60m
Total funding raised
$ 90m
Total funding raised
N/A
Total funding raised
$ 142m
For sources of this data, please see the company profile

View company profiles

Keros Therapeutics
HQ
Lexington, US
Employees
23

Keros Therapeutics is a biotechnology company dedicated to the discovery and development of therapeutics for hematological and musculoskeletal disorders.

View company
Apotheekzorg Bladel
HQ
Bladel, NL

Apotheekzorg Bladel is a provider of healthcare services.

View company
Zhimeng Biopharma
HQ
Employees
12

Zhimeng Biopharma (上海挚盟医药科技有限公司) is a biotech company developing medicines for the treatment of chronic hepatitis B (CHB) and severe neurological diseases.

View company